申请人:Grelan Pharmaceutical Co. Ltd.
公开号:US05872115A1
公开(公告)日:1999-02-16
This invention is concerned with 2-ureido-benzamide compounds of the formula (1) ##STR1## in which R.sup.1 is H, halogen atom, (C.sub.1 -C.sub.4)alkyl, (C.sub.1 -C.sub.4)alkoxy or (C.sub.1 -C.sub.4)dialkylamino and R.sup.2 is H, halogen atom, hydroxy, nitro, (C.sub.1 -C.sub.4)alkyl, (C.sub.1 -C.sub.4)alkoxy, (C.sub.3 -C.sub.6) cycloalkylmethoxy, (C.sub.1 -C.sub.4) alkylthio, (C.sub.1 -C.sub.4) alkylsulfinyl, (C.sub.1 -C.sub.4)alkylsulfonyl or ##STR2## wherein j is an integer of from 0 to 2 and R.sup.3 and R.sup.4 are each independently H, (C.sub.1 -C.sub.4)alkyl, (C.sub.1 -C.sub.4)alkanoyl, (C.sub.1 -C.sub.4)alkylsulfonyl or (C.sub.1 -C.sub.4)alkylcarbamoyl, NR.sup.3 R.sup.4 can to form a pyrrolidine, piperidine, morpholine, imidazole or pyrazole ring; X is a (C.sub.3 -C.sub.15)alkyl, (C.sub.3 -C.sub.6) cycloalkyl, (C.sub.3 -C.sub.6) cycloalkylmethyl, .omega.-(C.sub.1 -C.sub.4) alkoxy-(C.sub.1 -C.sub.4) alkyl group or ##STR3## wherein k is an integer of from 1 to 4 and R.sup.5 and R.sup.6 are each independently H, Y is H or (C.sub.1 -C.sub.4)alkyl and Z is ##STR4## wherein m is an integer of from 0 to 4.
这项发明涉及公式(1)中的2-脲基苯甲酰胺化合物,其中R^1为H、卤素原子、(C_1-C_4)烷基、(C_1-C_4)烷氧基或(C_1-C_4)二烷基胺,R^2为H、卤素原子、羟基、硝基、(C_1-C_4)烷基、(C_1-C_4)烷氧基、(C_3-C_6)环烷甲氧基、(C_1-C_4)烷硫基、(C_1-C_4)烷基亚砜基、(C_1-C_4)烷基砜基或##STR2##其中j为0到2的整数,R^3和R^4各自独立地为H、(C_1-C_4)烷基、(C_1-C_4)烷酰基、(C_1-C_4)烷基砜基或(C_1-C_4)烷基氨基甲酰基,NR^3R^4可以形成吡咯烷、哌啶、吗啉、咪唑或吡唑环;X为(C_3-C_15)烷基、(C_3-C_6)环烷基、(C_3-C_6)环烷基甲基、.omega.-(C_1-C_4)烷氧基-(C_1-C_4)烷基基团或##STR3##其中k为1到4的整数,R^5和R^6各自独立地为H,Y为H或(C_1-C_4)烷基,Z为##STR4##其中m为0到4的整数。